C

Co-Diagnostics
D

CODX

0.84780
USD
0.05
(6.20%)
مغلق
حجم التداول
700
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
27,070,044
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APT
    -0.04000
    (-0.73%)
    5.47000 USD
    A
    AYTU
    0.05000
    (2.92%)
    1.76000 USD
    N
    NVAX
    0.02500
    (0.28%)
    8.84500 USD
    O
    OPK
    -0.02500
    (-1.67%)
    1.47500 USD
    Q
    QDEL
    0.700
    (1.60%)
    44.450 USD
    T
    TTOO
    -0.02010
    (-8.04%)
    0.22990 USD
    V
    VXRT
    0.04570
    (5.96%)
    0.81290 USD
    المزيد
الأخبار
المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.